FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and represents an agent for local treatment of periodontal diseases, on the basis of organosilicone gycerohydrogel Si(C3H7O3)4·6C3H8O3·24H2O, containing therapeutic supplements, differing by the fact that the therapeutic supplements are presented by ketoprofen and methyluracil in the following proportions, wt %: ketoprofen - 0.5 - 1.0; methyluracil - 1.0 - 1.5; organosilicone gycerohydrogel Si(C3H7O3)4·6C3H8O3·24H2O - up to 100.
EFFECT: invention provides creating the effective agent applicable in the integrated therapy for treating the inflammatory periodontal diseases.
6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT FOR PARODENTIUM DISEASE | 2011 |
|
RU2457006C1 |
MEANS FOR TREATING INFLAMMATORY DISEASES OF PARODONTIUM | 2014 |
|
RU2566073C1 |
AGENT FOR LOCAL TREATMENT OF PERIODONTITIS AND METHOD OF TREATMENT OF PERIODONTITIS | 2022 |
|
RU2802822C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING HERPETIC INFECTIONS | 2014 |
|
RU2560686C2 |
PREPARATION FOR TREATING PERIODONTITIS | 2015 |
|
RU2604128C1 |
METHOD OF TREATING PERIODONTITIS AND ORAL MUCOSAL DISEASES ASSOCIATED WITH HELICOBACTER INFECTION, AND METHOD FOR USING IT | 2014 |
|
RU2549445C1 |
AGENT FOR TREATING PERIODONTITIS AND A METHOD OF TREATING PERIODONTITIS | 2020 |
|
RU2729428C1 |
METHOD FOR THE TREATMENT OF INFLAMMATORY PERIODONTAL DISEASES IN WOMEN IN THE MENOPAUSAL AND POSTMENOPAUSAL PERIODS | 2021 |
|
RU2763874C1 |
DENTAL GEL FOR REMINERALIZATION OF HARD TISSUES OF TEETH | 2022 |
|
RU2799030C1 |
AGENT FOR TREATING INFLAMMATORY ORAL DISEASES AND METHOD OF TREATING INFLAMMATORY ORAL DISEASES | 2011 |
|
RU2470640C1 |
Authors
Dates
2013-08-27—Published
2011-12-05—Filed